11:09 AM EDT, 05/13/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were heading lower late Tuesday morning, declining 0.27% to 1,415.23 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm Evaxion Biotech ( EVAX ) , which climbed 5.9% and 3.4% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and internet advertising firm Criteo ( CRTO ) , which advanced 2% and 1.4% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and pharmaceutical company Novo Nordisk ( NVO ) , which dropped 5.3% and 3.3% respectively. They were followed by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications ( SQNS ) , which lost 2.6% and 2.5%, respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which rose 3.3% and 2.5% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and financial services company Lloyds Banking Group ( LYG ) , which were up 2.2% and 1.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and biotech firm Autolus Therapeutics ( AUTL ) , which fell 13% and 7.4% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group plc ( MREO ) and Bicycle Therapeutics ( BCYC ) , which were down 7.6% and 5.1% respectively.